Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

January 15, 2022

Study Completion Date

January 15, 2022

Conditions
Post-stroke DepressionPost-stroke Aphasia
Interventions
BEHAVIORAL

Intensive communicative-pragmatic social interaction.

"ILAT requires individuals with aphasia to engage in social interaction. Groups of three patients and a therapist are seated around a table and provided with picture cards showing different objects (e.g., bottle). Each card has a duplicate that is owned by one of the other players. The goal is to obtain this duplicate from a fellow player by requesting the depicted object (e.g., Give me the \[…\]). If the duplicate is available, the addressee hands over the corresponding card to the person who initiated the request sequence. If the duplicate is not available, the addressee rejects the request. In the event of misunderstandings, the players ask clarifying questions. Throughout the training, participants use formulaic expressions to indicate whether a request is accepted (Here you are, Thank you, You're welcome), rejected (I'm sorry, No problem, Too bad) or unclear (Pardon me?). Treatment duration will be four weeks."

BEHAVIORAL

Standard care.

Depending on the participants' diagnoses and needs, standard care will include: occupational therapy (2-3 hours of weekly practice), physiotherapy (3 hours of weekly practice), and speech-language therapy (2-3 hours of weekly practice with non-communicative, impairment-specific exercises). Standard care will be delivered in accordance with state-of-the-art procedures in rehabilitation centers certified in Germany. Treatment duration will be four weeks.

Trial Locations (1)

14089

MEDIAN-Klinik Berlin-Kladow, Berlin

All Listed Sponsors
lead

University Medicine Greifswald

OTHER

NCT04318951 - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia | Biotech Hunter | Biotech Hunter